Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of GUJ.TERC LAB. For more details, see the GUJ.TERC LAB quarterly results and GUJ.TERC LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.0 |
No. of shares | m | 7.42 |
1 Week | % | 11.2 |
1 Month | % | 40.4 |
1 Year | % | 218.2 |
52 week H/L | Rs | 70.9/16.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
GUJ.TERC LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 13 | 10 | 10 | 29 | 43 | |
Low | Rs | 6 | 6 | 6 | 7 | 15 | |
Sales per share (Unadj.) | Rs | 41.8 | 50.6 | 33.9 | 54.1 | 63.0 | |
Earnings per share (Unadj.) | Rs | 0.6 | 0.4 | -3.4 | 1.2 | -2.3 | |
Diluted earnings per share | Rs | 0.6 | 0.4 | -3.4 | 1.2 | -2.3 | |
Cash flow per share (Unadj.) | Rs | 0.9 | 0.7 | -3.2 | 1.5 | -1.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 14.6 | 15.0 | 10.3 | 11.5 | 9.2 | |
Adj. book value per share | Rs | 14.6 | 15.0 | 10.3 | 11.5 | 9.2 | |
Shares outstanding (eoy) | m | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | |
Price / Sales ratio | x | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 | |
Avg P/E ratio | x | 16.9 | 20.9 | -2.4 | 15.0 | -12.9 | |
P/CF ratio (eoy) | x | 11.3 | 11.1 | -2.6 | 11.4 | -16.5 | |
Price / Book Value ratio | x | 0.7 | 0.5 | 0.8 | 1.5 | 3.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 73 | 58 | 61 | 131 | 215 | |
Total wages/salary | Rs m | 128 | 148 | 126 | 155 | 202 |
GUJ.TERC LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 310 | 375 | 252 | 401 | 468 | |
Other income | Rs m | 3 | 3 | 8 | 3 | 4 | |
Total revenues | Rs m | 314 | 378 | 260 | 404 | 471 | |
Gross profit | Rs m | 5 | 7 | -28 | 11 | -22 | |
Depreciation | Rs m | 2 | 2 | 2 | 3 | 4 | |
Interest | Rs m | 3 | 3 | 4 | 4 | 7 | |
Profit before tax | Rs m | 3 | 4 | -25 | 7 | -29 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -1 | 2 | 0 | -1 | -12 | |
Profit after tax | Rs m | 4 | 3 | -25 | 9 | -17 | |
Gross profit margin | % | 1.6 | 1.8 | -11.0 | 2.8 | -4.6 | |
Effective tax rate | % | -25.1 | 36.6 | 0.5 | -16.8 | 42.2 | |
Net profit margin | % | 1.4 | 0.7 | -10.0 | 2.2 | -3.6 |
GUJ.TERC LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 92 | 119 | 120 | 155 | 160 | |
Current liabilities | Rs m | 67 | 93 | 117 | 132 | 166 | |
Net working cap to sales | % | 8.2 | 7.0 | 1.2 | 5.6 | -1.2 | |
Current ratio | x | 1.4 | 1.3 | 1.0 | 1.2 | 1.0 | |
Inventory Days | Days | 95 | 79 | 105 | 80 | 54 | |
Debtors Days | Days | 53,265,972 | 68,121 | 750 | 498 | 623 | |
Net fixed assets | Rs m | 101 | 104 | 97 | 116 | 110 | |
Share capital | Rs m | 74 | 74 | 74 | 74 | 74 | |
"Free" reserves | Rs m | 34 | 37 | 2 | 11 | -6 | |
Net worth | Rs m | 108 | 111 | 77 | 85 | 69 | |
Long term debt | Rs m | 1 | 2 | 4 | 23 | 15 | |
Total assets | Rs m | 193 | 223 | 217 | 271 | 270 | |
Interest coverage | x | 2.4 | 2.5 | -5.5 | 2.9 | -3.0 | |
Debt to equity ratio | x | 0 | 0 | 0.1 | 0.3 | 0.2 | |
Sales to assets ratio | x | 1.6 | 1.7 | 1.2 | 1.5 | 1.7 | |
Return on assets | % | 3.5 | 2.5 | -9.8 | 4.7 | -3.5 | |
Return on equity | % | 4.0 | 2.5 | -32.9 | 10.2 | -24.4 | |
Return on capital | % | 5.5 | 6.5 | -26.5 | 10.6 | -26.1 | |
Exports to sales | % | 0.5 | 0.2 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 1 | 1 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1 | 1 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 1 | 1 | 0 | 0 | 0 |
GUJ.TERC LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -6 | -16 | -2 | -4 | 0 | |
From Investments | Rs m | -1 | -3 | -4 | -24 | 6 | |
From Financial Activity | Rs m | 2 | 17 | 18 | 15 | -1 | |
Net Cashflow | Rs m | -6 | -1 | 12 | -13 | 5 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Natwarbhai P Prajapati | COMP SEC: Ashka Solanki | YEAR OF INC: 1985 | BSE CODE: 524314 | FV (Rs): 10 | DIV YIELD (%): - |
Read: GUJ.TERC LAB 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare GUJ.TERC LAB With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.